The pharmaceutical industry continuously seeks efficient and reliable methods for synthesizing complex drug molecules. (3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone, identified by its CAS number 68711-40-0, plays a pivotal role in this pursuit, primarily as a key intermediate in the synthesis of Orlistat, a prominent medication for weight management.

NINGBO INNO PHARMCHEM CO.,LTD. is a leading supplier of this critical pharmaceutical intermediate. The precise chemical synthesis of (3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone is essential for ensuring the efficacy and safety of the final Orlistat product. The compound's structural features and high purity are paramount for successful drug manufacturing processes.

Beyond its direct role in Orlistat production, this oxetanone derivative is also recognized as an analog of Tetrahydrolipstatin, an inhibitor of endocannabinoid 2-arachidonoylglycerol (2-AG). This dual identity makes it valuable not only for bulk manufacturing but also for research purposes, including the study of metabolic pathways and the development of novel therapeutic compounds.

Moreover, CAS 68711-40-0 serves as an important reference standard for Orlistat impurities. The availability of high-quality impurity standards is indispensable for pharmaceutical quality assurance, enabling accurate detection and quantification of any deviations from the desired product profile. NINGBO INNO PHARMCHEM CO.,LTD. ensures that these standards meet the exacting requirements of regulatory bodies.

The contribution of compounds like (3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone to the pharmaceutical supply chain is substantial. By providing reliable access to essential chemical intermediates and standards, NINGBO INNO PHARMCHEM CO.,LTD. supports the critical work of drug manufacturers, contributing to the availability of effective treatments for patients worldwide.